Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549–BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification-Reference-Cited by-同舟云学术

Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549–BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification

Published:2015-06-27 Issue:1 Volume:142 Page:89-100
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Gierke Midea,Sperveslage Jan,Schwab David,Beschorner Rudi,Ebinger Martin,Schuhmann Martin U.,Schittenhelm Jens

Funder

Ludwig-Hiermeier foundation of applied cancer research

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-015-2006-2.pdf

Reference49 articles.

1. Antonelli M, Badiali M, Moi L, Buttarelli FR, Baldi C, Massimino M, Sanson M, Giangaspero F (2015) KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis. Pediatr Blood Cancer 62(4):724–727

2. Arcaini L, Zibellini S, Boveri E, Riboni R, Rattotti S, Varettoni M, Guerrera ML, Lucioni M, Tenore A, Merli M, Rizzi S, Morello L, Cavalloni C, Da Vià MC, Paulli M, Cazzola M (2012) The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood 119:188–191

3. Badiali M, Gleize V, Paris S, Moi L, Elhouadani S, Arcella A, Morace R, Antonelli M, Buttarelli FR, Figarella-Branger D, Kim YH, Ohgaki H, Mokhtari K, Sanson M, Giangaspero F (2012) KIAA1549-BRAF fusions and IDH mutations can coexist in diffuse gliomas of adults. Brain Pathol 22:841–847

4. Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales La Madrid A, Marcus KJ, Guo D, Ullrich NJ, Robison NJ, Chi SN, Beroukhim R, Kieran MW, Manley PE (2014) Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Pediatr Blood Cancer 61:1173–1179

5. Buccoliero AM, Castiglione F, Degl’Innocenti DR, Gheri CF, Genitori L, Taddei GL (2012) IDH1 mutation in pediatric gliomas: has it a diagnostic and prognostic value? Fetal Pediatr Pathol 31:278–282

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological analysis of BRAF and non-BRAF MAPK pathway-altered gliomas in paediatric and adult patients: a single-institution study of 40 patients;Journal of Clinical Pathology;2024-01-09

2. Unlocking the power of precision medicine for pediatric low-grade gliomas: molecular characterization for targeted therapies with enhanced safety and efficacy;Frontiers in Oncology;2023-06-15

3. Treatment of Pediatric Low-Grade Gliomas;Current Neurology and Neuroscience Reports;2023-03-07

4. Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution;Frontiers in Oncology;2023-01-04

5. Pediatric Central Nervous System Cancers, Version 2.2023;J NATL COMPR CANC NE;2022